Literature DB >> 17712253

On the assessment of preferences for health and duration: maximal endurable time and better than dead preferences.

Peep F M Stalmeier1, Leida M Lamers, Jan J V Busschbach, Paul F M Krabbe.   

Abstract

BACKGROUND: Several studies revealed difficulties with the valuation and analysis of health states deemed worse than dead. These problems may be linked to maximal endurable time (MET) preferences, the phenomenon that for severe states better than dead (BTD), shorter durations are often preferred to longer durations.
OBJECTIVE: To test the association between the duration of health states and their valuation.
METHODS: A representative sample of 123 Dutch respondents (age range, 18-45 years) valued 5 EQ-5D health states. With a straightforward method using BTD preferences, respondents indicated whether a state of a certain duration is better, equal to, or worse than dead. To validate these BTD preferences, MET preferences (whether a longer duration of a health state is better, equal, or worse than a shorter duration) were collected.
RESULTS: BTD and MET preferences were strongly related (P < 0.001). For severe health states, although still judged as better than dead, BTD preferences curved downwards with increasing duration. Such curved BTD patterns occurred in 28% of the respondents, especially for more severe states (P < 0.001).
CONCLUSIONS: BTD preferences revealed that the value of moderate and severe states declines with increasing duration, suggesting that health and duration interact. For states worse than dead versus states better than dead, traditional valuation techniques have the drawback that different preference questions are used. Using BTD preferences, however, a single simple preference question can assess states better than dead, as well as states worse than dead.

Entities:  

Mesh:

Year:  2007        PMID: 17712253     DOI: 10.1097/MLR.0b013e3180ca9ac5

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  16 in total

1.  Empirical validation of patient versus population preferences in calculating QALYs.

Authors:  Eva-Julia Weyler; Afschin Gandjour
Journal:  Health Serv Res       Date:  2011-04-21       Impact factor: 3.402

2.  Time trade-off and attitudes toward euthanasia: implications of using 'death' as an anchor in health state valuation.

Authors:  Liv A Augestad; Kim Rand-Hendriksen; Knut Stavem; Ivar Sønbø Kristiansen
Journal:  Qual Life Res       Date:  2012-06-08       Impact factor: 4.147

Review 3.  Using QALYs in cancer: a review of the methodological limitations.

Authors:  Martina Garau; Koonal K Shah; Anne R Mason; Qing Wang; Adrian Towse; Michael F Drummond
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

4.  Health Valuation: Demonstrating the Value of Health and Lifespan.

Authors:  Elly A Stolk; Benjamin M Craig; Brendan Mulhern; Derek S Brown
Journal:  Patient       Date:  2017-08       Impact factor: 3.883

5.  Maximal endurable time states and the standard gamble: more preference reversals.

Authors:  P F M Stalmeier; A L Verheijen
Journal:  Eur J Health Econ       Date:  2012-12-09

6.  Valuation of EQ-5D-3L health states in Singapore: modeling of time trade-off values for 80 empirically observed health states.

Authors:  Nan Luo; Pei Wang; Julian Thumboo; Yee-Wei Lim; Hubertus J M Vrijhoef
Journal:  Pharmacoeconomics       Date:  2014-05       Impact factor: 4.981

7.  The better than dead method: feasibility and interpretation of a valuation study.

Authors:  R A van Hoorn; A R T Donders; M Oppe; P F M Stalmeier
Journal:  Pharmacoeconomics       Date:  2014-08       Impact factor: 4.981

8.  Values for health states with different life durations.

Authors:  Luciana Scalone; Peep F M Stalmeier; Silvano Milani; Paul F M Krabbe
Journal:  Eur J Health Econ       Date:  2014-09-30

Review 9.  Valuation of health states in the US study to establish disability weights: lessons from the literature.

Authors:  Jürgen Rehm; Ulrich Frick
Journal:  Int J Methods Psychiatr Res       Date:  2010-03       Impact factor: 4.035

10.  EuroQol (EQ-5D) health utility scores for patients with migraine.

Authors:  Ruifeng Xu; Ralph P Insinga; Wendy Golden; X Henry Hu
Journal:  Qual Life Res       Date:  2010-11-10       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.